COMMUNIQUÉS West-GlobeNewswire

CooperCompanies Announces New Chair of the Board and Strategic Review
04/12/2025
SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that its Board of Directors has appointed Colleen Jay to succeed current Chair Robert [...]
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/12/2025
BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 40,650 restricted stock units (“RSUs”) and options to purchase 38,850 shares [...]
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
04/12/2025
– CAPTAIN is the first randomized controlled trial ever comparing a new technology to the standard of care of robotic radical prostatectomy to successfully recruit to target – TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- [...]
CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies
04/12/2025
Phase 2b trial showed significant improvements on primary and key secondary outcomes measures, most prominently in patients without AD co-pathology Significant reduction in key neurodegeneration biomarker correlated [...]
Aveanna to Participate at the BofA Securities Home Care Conference
04/12/2025
ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the BofA Securities Home Care Conference virtually on December [...]
MEDIROM Mother Labs Partners with TD SYNNEX to Accelerate National Adoption of "MOTHER Bracelet" and "REMONY"
04/12/2025
TOKYO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) today announced that its subsidiary, MEDIROM MOTHER Labs Inc. (“MOTHER Labs”), which develops health-tech solutions [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/12/2025
VANCOUVER, British Columbia and BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, [...]
Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA
05/12/2025
ROCKVILLE, Md. and SUZHOU, China, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the [...]
Mental Health Experts Available for a Variety of Mental Health Topics
04/12/2025
Spokespeople from Talkspace Available for Interviews, Quotes and Rapid-Response Commentary New York, NY, Dec. 04, 2025 (GLOBE NEWSWIRE) -- As newsrooms continue covering the growing mental health crisis, especially [...]
Sabin Vaccine Institute’s Investigational Marburg Vaccine Delivered to Ethiopia for Outbreak Response
04/12/2025
WASHINGTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) has sent more than 640 doses of its investigational cAd3-Marburg Vaccine to Ethiopia to support the country’s response to its first-ever [...]
Zhittya Genesis Medicine Announces Initial Results Suggesting Potential Reversal of Type 2 Diabetes in Human Study
04/12/2025
Groundbreaking discovery points to a potential disease-reversing treatment for Type-2 Diabetes LAS VEGAS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine today announced promising initial results from a human [...]
Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
04/12/2025
Kensington, MD, USA and Munich/Martinsried, Germany, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small [...]
SAFE - Résultats annuels 2024 - Mise à disposition du rapport annuel 2024
04/12/2025
Résultats annuels 2024 Mise à disposition du rapport annuel 2024 Fleurieux-sur-l’Arbresle – France – 4 décembre 2025 – 20h - Safe (FR001400ZU25 – ALSAF) (la « Société ») annonce ses résultats annuels et avoir mis à la [...]
Latest Legal Anabolic Steroid Alternatives for Bodybuilding 2026: Natural Steroids for Muscle Building & Cutting Fat Introduced by CrazyBulk
04/12/2025
Legal Anabolic Steroid Alternatives for Bodybuilding from CrazyBulk in 2026: Best Selling Natural Steroids for Muscle Building and Cutting Fat. New York City, NY, Dec. 04, 2025 (GLOBE NEWSWIRE) -- In 2026, there is [...]
GATC Health to Host Virtual KOL Event to Discuss Derisq™ AI Report: Predictive, Detailed Risk Assessment of Drug Candidates, on December 10, 2025
04/12/2025
BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, announced that it will host a virtual key [...]
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
04/12/2025
SAN DIEGO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics, today announced the commencement of a [...]
Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
04/12/2025
Praxis confirms plans to submit the essential tremor NDA for ulixacaltamide in early 2026 BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical [...]
ImPact Biotech Presents Updated Preliminary Data from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at SUO 2025
04/12/2025
– Complete response (CR) observed in 70% (35/50) of patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) – Initial durability data shows all patients (100%) who [...]
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
04/12/2025
ARLINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced that it has entered into definitive agreements for the purchase of an aggregate of 10,000,000 [...]

Pages